Regulatory and pathogenetic mechanisms of autoantibodies in SLE

References

• Robbins WC, Holman HR, Deicher H, Kunkel HG. Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med. 1957; 96:575–579.
   PubMed Web of Science ®Google Scholar
• Ceppellini R, Polli E, Celada F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med. 1957; 96:572–574.
   PubMed Web of Science ®Google Scholar
• Miescher P. [Serology of the L.E. phenomenon.]. Hautarzt. 1957; 8:502–505.
   Google Scholar
• Radic MZ, Erikson J, Litwin S, Weigert M. B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med. 1993; 177:1165–1173.
   PubMed Web of Science ®Google Scholar
• Witsch EJ, Cao H, Fukuyama H, Weigert M. Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med. 2006; 203:1761–1772.
   Google Scholar
• Tiegs SL, Russell DM, Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med. 1993; 177:1009–1020.
   PubMed Web of Science ®Google Scholar
• Yachimovich N, Mostoslavsky G, Yarkoni Y, Verbovetski I, Eilat D. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status. Eur J Immunol. 2002; 32:1164–1174.
   Google Scholar
• Yachimovich-Cohen N, Fischel R, Bachar N, Yarkoni Y, Eilat D. Autoimmune NZB/NZWF1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors. Eur J Immunol. 2003; 33:2469–2478.
   PubMedGoogle Scholar
• Scholz JL, Crowley JE, Tomayko MM, Steinel N, O'Neill PJ, Quinn WJ3rd, Goenka R, Miller JP, Cho YH, Long V, Ward C, Migone TS, Shlomchik MJ, Cancro MP. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci USA. 2008; 105:15517–15522.
   PubMed Web of Science ®Google Scholar
• Stadanlick JE, Kaileh M, Karnell FG, Scholz JL, Miller JP, Quinn WJ3rd, Brezski RJ, Treml LS, Jordan KA, Monroe JG, Sen R, Cancro MP. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol. 2008; 9:1379–1387.
   PubMed Web of Science ®Google Scholar
• Grimaldi CM, Jeganathan V, Diamond B. Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J Immunol. 2006; 176:2703–2710.
   PubMed Web of Science ®Google Scholar
• Ramanujam M, Wang X, Huang W, Liu Z, Schiffer L, Tao H, Frank D, Rice J, Diamond B, Yu KO, Porcelli S, Davidson A. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest. 2006; 116:724–734.
   PubMed Web of Science ®Google Scholar
• Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity. 2007; 26:205–213.
   PubMed Web of Science ®Google Scholar
• Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, Abraham K, Gonzalez JB, Pascual V, Stichweh D, Wardemann H, Nussenzweig MC. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci USA. 2008; 105:9727–9732.
   PubMed Web of Science ®Google Scholar
• Avalos AM, Busconi L, Marshak-Rothstein A. Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity. 2010; 43:76–83.
   PubMed Web of Science ®Google Scholar
• Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature. 2002; 416:603–607.
   PubMed Web of Science ®Google Scholar
• Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P, Richards RJ, Liu CL, Cheung R, Utz PJ, Marshak-Rothstein A, Rifkin IR. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB − / − Yaa and FcgammaRIIB − / − mouse models of systemic lupus erythematosus. J Immunol. 2010; 184:796–806.
   PubMed Web of Science ®Google Scholar
• Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 2010; 6:280–289.
   PubMed Web of Science ®Google Scholar
• Munoz LE, Janko C, Chaurio RA, Schett G, Gaipl US, Herrmann M. IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE. Autoimmunity. 2010; 43:232–235.
   PubMed Web of Science ®Google Scholar
• Finke D, Eloranta ML, Ronnblom L. Endogenous type I interferon inducers in autoimmune diseases. Autoimmunity. 2009; 42:349–352.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS, Fairhurst AM. The origin of extracellular DNA during the clearance of dead and dying cells. Autoimmunity. 2007; 40:281–284.
   PubMed Web of Science ®Google Scholar
• Cline AM, Radic MZ. Murine lupus autoantibodies identify distinct subsets of apoptotic bodies. Autoimmunity. 2004; 37:85–93.
   PubMed Web of Science ®Google Scholar
• Reich CF3rd, Pisetsky DS. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp Cell Res. 2009; 315:760–768.
   PubMed Web of Science ®Google Scholar
• Fransen JH, Hilbrands LB, Ruben J, Stoffels M, Adema GJ, van der Vlag J, Berden JH. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum. 2009; 60:2304–2313.
   PubMed Web of Science ®Google Scholar
• Fransen JH, van der Vlag J, Ruben J, Adema GJ, Berden JH, Hilbrands LB. The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther. 2010; 12:207.
   PubMed Web of Science ®Google Scholar
• van Bavel CC, Dieker J, Muller S, Briand JP, Monestier M, Berden JH, van de Vlag J. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol. 2009; 47:511–516.
   PubMed Web of Science ®Google Scholar
• Dieker JW, Fransen JH, Van Bavel CC, Briand JP, Jacobs CW, Muller S, Berden JH, van der Vlag J. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 2007; 56:1921–1933.
   PubMed Web of Science ®Google Scholar
• Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol. 2008; 180:1895–1902.
   PubMed Web of Science ®Google Scholar
• Schiraldi M, Monestier M. How can a chemical element elicit complex immunopathology? Lessons from mercury-induced autoimmunity. Trends Immunol. 2009; 30:502–509.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Jost M, Gaughan JP, Class R, Coyle AJ, Monestier M. ICOS-B7 homologous protein interactions are necessary for mercury-induced autoimmunity. J Immunol. 2005; 174:3117–3121.
   PubMedGoogle Scholar
• van Bavel CC, Fenton KA, Rekvig OP, van der Vlag J, Berden JH. Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 2008; 58:1892–1899.
   PubMedGoogle Scholar
• Mortensen ES, Rekvig OP. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J Am Soc Nephrol. 2009; 20:696–704.
   PubMed Web of Science ®Google Scholar
• Fenton K, Tommeras B, Marion TN, Rekvig OP. Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity. 2010; 43:179–188.
   Web of Science ®Google Scholar
• Fenton K, Fismen S, Hedberg A, Seredkina N, Fenton C, Mortensen ES, Rekvig OP. Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One. 2009; 4:e8474.
   Google Scholar
• Liang Z, Chang S, Youn MS, Mohan C. Molecular hallmarks of anti-chromatin antibodies associated with the lupus susceptibility locus, Sle1. Mol Immunol. 2009; 46:2671–2681.
   Google Scholar
• Vuyyuru R, Mohan C, Manser T, Rahman ZS. The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints. J Immunol. 2009; 183:5716–5727.
   PubMed Web of Science ®Google Scholar
• Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: The first fifty patients. Arthritis Rheum. 2009; 61:482–487.
   PubMed Web of Science ®Google Scholar
• Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D'Cruz DP, Isenberg DA, Rahman A. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: A prospective longitudinal study. Arthritis Res Ther. 2009; 11:R154.
   PubMed Web of Science ®Google Scholar
• Amital H, Heilweil-Harel M, Ulmansky R, Harlev M, Toubi E, Hershko A, Naparstek Y. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology (Oxford). 2007; 46:1433–1437.
   PubMed Web of Science ®Google Scholar
• Yin H, Borghi MO, Delgado-Vega AM, Tincani A, Meroni PL, Alarcon-Riquelme ME. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome. Rheum. 2009; 60:2468–2471.
   Google Scholar
• Fredi M, Tincani A, Yin H, Delgado-Vega AM, Borghi MO, Meroni PL, Alarcon-Riquelme ME. IRF5 is associated with primary antiphospholipid syndrome, but is not a major risk factor. Arthritis Rheum. 2010; 62:1201–1202.
   PubMed Web of Science ®Google Scholar
• Munoz LE, van Bavel CC, Franz S, Berden JH, Herrmann M, van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus. 2008; 17:371–375.
   PubMed Web of Science ®Google Scholar